Rucaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor used in the treatment of recurrent ovarian and prostate cancers in adults who have previously undergone other treatments.
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search Results for " Rucaparib "
Rucaparib Related Products
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Rucaparib, pharmacopeial and non-pharmacopeial Rucaparib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Rucaparib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Rucaparib-related products are thoroughly characterized. Rucaparib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.